Skip to Content

Sucroferric Oxyhydroxide

In the US, Sucroferric Oxyhydroxide (sucroferric oxyhydroxide systemic) is a member of the drug class phosphate binders and is used to treat Hyperphosphatemia of Renal Failure.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Therapeutic Category

Phosphate binder for treatment of hyperphosphatemia

Chemical Name

polynuclear iron(III) oxyhydroxide stabilized with sucrose and starches (USAN)

Foreign Names

  • Eisen(III)-oxidhydroxid-Saccharose-Stärke-Komplex (German)
  • Oxyhydroxyde de fer(III) polynucléaire (French)
  • Oxihidróxido Sucroferric (Spanish)

Generic Names

  • Sucroferric Oxyhydroxide (OS: USAN)
  • Ferrioxyhydroxid (IS)
  • Ferrioxyhydroxidum (IS)
  • Ferrioxyhydroxidum/Saccharum/Amyla (IS)
  • Oxyhydroxyde de fer(III) polynucléaire dans un mélange de saccharose et d'amidon (IS)
  • Polynukleares Eisen(III)-Oxidhydroxid in einer Mischung mit Saccharose und Stärke (IS)

Brand Names

  • Velphoro
    Fresenius Medical Care North America, United States; Vifor, Germany; Vifor, Ireland; Vifor Fresenius Medical Care Renal Pharma, Switzerland


ISInofficial Synonym
OSOfficial Synonym
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.